Cargando…
Admission High-Sensitivity Cardiac Troponin vs a Biochemical Score for Predicting Mortality in Patients With COVID-19
Autores principales: | Kavsak, Peter A., Mondoux, Shawn E., de Wit, Kerstin, Rochwerg, Bram, Main, Cheryl, Yamamura, Deborah, Paré, Guillaume, Ma, Jinhui, Perri, Dan, Sherbino, Jonathan, Worster, Andrew |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7553859/ https://www.ncbi.nlm.nih.gov/pubmed/33073223 http://dx.doi.org/10.1016/j.cjco.2020.10.008 |
Ejemplares similares
-
Important Differences Between Manufacturers When Transitioning From a Contemporary Cardiac Troponin Assay to a High-Sensitivity Cardiac Troponin Assay
por: Kavsak, Peter A., et al.
Publicado: (2021) -
High-Sensitivity Cardiac Troponin I vs a Clinical Chemistry Score for Predicting All-Cause Mortality in an Emergency Department Population
por: Kavsak, Peter A., et al.
Publicado: (2020) -
Acute Phase Response and Non-Reproducible Elevated Concentrations with a High-Sensitivity Cardiac Troponin I Assay
por: Kavsak, Peter A., et al.
Publicado: (2021) -
Can the Addition of NT-proBNP and Glucose Measurements Improve the Prognostication of High-Sensitivity Cardiac Troponin Measurements for Patients with Suspected Acute Coronary Syndrome?
por: Kavsak, Peter A., et al.
Publicado: (2021) -
Risk Stratification for Patients with Chest Pain Discharged Home from the Emergency Department
por: Kavsak, Peter A., et al.
Publicado: (2020)